505 related articles for article (PubMed ID: 15690135)
1. Proton magnetic resonance spectroscopy in immunocompetent patients with primary central nervous system lymphoma.
Raizer JJ; Koutcher JA; Abrey LE; Panageas KS; DeAngelis LM; Lis E; Xu S; Zakian KL
J Neurooncol; 2005 Jan; 71(2):173-80. PubMed ID: 15690135
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal multivoxel MR spectroscopy study of pediatric diffuse brainstem gliomas treated with radiotherapy.
Laprie A; Pirzkall A; Haas-Kogan DA; Cha S; Banerjee A; Le TP; Lu Y; Nelson S; McKnight TR
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):20-31. PubMed ID: 15850898
[TBL] [Abstract][Full Text] [Related]
3. Multisection 1H magnetic resonance spectroscopic imaging assessment of glioma response to chemotherapy.
Balmaceda C; Critchell D; Mao X; Cheung K; Pannullo S; DeLaPaz RL; Shungu DC
J Neurooncol; 2006 Jan; 76(2):185-91. PubMed ID: 16151595
[TBL] [Abstract][Full Text] [Related]
4. [Application of (1)H MR spectroscopic imaging in radiation oncology: choline as a marker for determining the relative probability of tumor progression after radiation of glial brain tumors].
Lichy MP; Bachert P; Hamprecht F; Weber MA; Debus J; Schulz-Ertner D; Schlemmer HP; Kauczor HU
Rofo; 2006 Jun; 178(6):627-33. PubMed ID: 16703499
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the lactate-to-N-acetyl-aspartate ratio defined with magnetic resonance spectroscopic imaging before radiation therapy as a new predictive marker of the site of relapse in patients with glioblastoma multiforme.
Deviers A; Ken S; Filleron T; Rowland B; Laruelo A; Catalaa I; Lubrano V; Celsis P; Berry I; Mogicato G; Cohen-Jonathan Moyal E; Laprie A
Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):385-93. PubMed ID: 25104068
[TBL] [Abstract][Full Text] [Related]
6. Proton magnetic resonance spectroscopic findings of cerebral fat embolism induced by triolein emulsion in cats.
Baik SK; Kim YW; Kim HJ; Lee JW; Cho BM; Kim DH; Choi SH; Lee SH; Chang KH
Acta Radiol; 2008 Dec; 49(10):1174-81. PubMed ID: 19031181
[TBL] [Abstract][Full Text] [Related]
7. Central nervous system lymphoma characterization by diffusion-weighted imaging and MR spectroscopy.
Zacharia TT; Law M; Naidich TP; Leeds NE
J Neuroimaging; 2008 Oct; 18(4):411-7. PubMed ID: 18494774
[TBL] [Abstract][Full Text] [Related]
8. 3-Dimensional magnetic resonance spectroscopic imaging at 3 Tesla for early response assessment of glioblastoma patients during external beam radiation therapy.
Muruganandham M; Clerkin PP; Smith BJ; Anderson CM; Morris A; Capizzano AA; Magnotta V; McGuire SM; Smith MC; Bayouth JE; Buatti JM
Int J Radiat Oncol Biol Phys; 2014 Sep; 90(1):181-9. PubMed ID: 24986746
[TBL] [Abstract][Full Text] [Related]
9. MR spectroscopy using normalized and non-normalized metabolite ratios for differentiating recurrent brain tumor from radiation injury.
Elias AE; Carlos RC; Smith EA; Frechtling D; George B; Maly P; Sundgren PC
Acad Radiol; 2011 Sep; 18(9):1101-8. PubMed ID: 21820634
[TBL] [Abstract][Full Text] [Related]
10. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
[TBL] [Abstract][Full Text] [Related]
11. Improved delineation of brain tumors: an automated method for segmentation based on pathologic changes of 1H-MRSI metabolites in gliomas.
Stadlbauer A; Moser E; Gruber S; Buslei R; Nimsky C; Fahlbusch R; Ganslandt O
Neuroimage; 2004 Oct; 23(2):454-61. PubMed ID: 15488395
[TBL] [Abstract][Full Text] [Related]
12. Axonal damage in multiple sclerosis plaques: a combined magnetic resonance imaging and 1H-magnetic resonance spectroscopy study.
Simone IL; Tortorella C; Federico F; Liguori M; Lucivero V; Giannini P; Carrara D; Bellacosa A; Livrea P
J Neurol Sci; 2001 Jan; 182(2):143-50. PubMed ID: 11137520
[TBL] [Abstract][Full Text] [Related]
13. Long-term cerebral metabolite changes on proton magnetic resonance spectroscopy in patients cured of acute lymphoblastic leukemia with previous intrathecal methotrexate and cranial irradiation prophylaxis.
Chan YL; Roebuck DJ; Yuen MP; Yeung KW; Lau KY; Li CK; Chik KW
Int J Radiat Oncol Biol Phys; 2001 Jul; 50(3):759-63. PubMed ID: 11395245
[TBL] [Abstract][Full Text] [Related]
14. Single- and multivoxel proton spectroscopy in pediatric patients with diffuse intrinsic pontine glioma.
Steffen-Smith EA; Venzon DJ; Bent RS; Hipp SJ; Warren KE
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):774-9. PubMed ID: 22445531
[TBL] [Abstract][Full Text] [Related]
15. Correlation of basal ganglia magnetic resonance spectroscopy with Apgar score in perinatal asphyxia.
Pavlakis SG; Kingsley PB; Harper R; Buckwald S; Spinazzola R; Frank Y; Prohovnik I
Arch Neurol; 1999 Dec; 56(12):1476-81. PubMed ID: 10593302
[TBL] [Abstract][Full Text] [Related]
16. Differentiation between brain tumor recurrence and radiation injury using MR spectroscopy.
Weybright P; Sundgren PC; Maly P; Hassan DG; Nan B; Rohrer S; Junck L
AJR Am J Roentgenol; 2005 Dec; 185(6):1471-6. PubMed ID: 16304000
[TBL] [Abstract][Full Text] [Related]
17. Temporal pole proton preoperative magnetic resonance spectroscopy in patients undergoing surgery for mesial temporal sclerosis.
Fountas KN; Tsougos I; Gotsis ED; Giannakodimos S; Smith JR; Kapsalaki EZ
Neurosurg Focus; 2012 Mar; 32(3):E3. PubMed ID: 22380857
[TBL] [Abstract][Full Text] [Related]
18. Correlations between magnetic resonance spectroscopy and image-guided histopathology, with special attention to radiation necrosis.
Rock JP; Hearshen D; Scarpace L; Croteau D; Gutierrez J; Fisher JL; Rosenblum ML; Mikkelsen T
Neurosurgery; 2002 Oct; 51(4):912-9; discussion 919-20. PubMed ID: 12234397
[TBL] [Abstract][Full Text] [Related]
19. Utility of proton MR spectroscopy for differentiating typical and atypical primary central nervous system lymphomas from tumefactive demyelinating lesions.
Lu SS; Kim SJ; Kim HS; Choi CG; Lim YM; Kim EJ; Kim DY; Cho SH
AJNR Am J Neuroradiol; 2014 Feb; 35(2):270-7. PubMed ID: 23928144
[TBL] [Abstract][Full Text] [Related]
20. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
